Clinical Trial

Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration

Study acronym: NOGA1
Recruiting
View on ClinicalTrials.gov →
Summary
Age-related macular degeneration (AMD) is the leading cause of visual impairment in industrialized countries. Anatomical examination findings at the early and intermediate stages of AMD are not sufficient to determine any functional alterations at these stages (e.g., alterations in microperimetry, multifocal electroretinogram (mfERG) and contrast sensitivity). Identifying early functional markers of the disease is a necessary first step in the development and clinical validation of treatments to slow progression to advanced disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-11-15; most recent amendment 2025-04-28.
Status change: Not Yet Recruiting → Recruiting 2025-04-28
Trial Details
NCT Number NCT06694272
Lead Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Conditions Age Related Macular Degeneration
Enrollment 120 participants
Start Date 2025-04-09
Primary Completion 2031-04 (estimated)
Study Completion 2031-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-29